Diploma PLC (LON:DPLM)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 0 ($0.00) and traded as high as GBX 2,974 ($38.86). Diploma shares last traded at GBX 2,888 ($37.73), with a volume of 261,899 shares.
A number of analysts recently weighed in on the stock. Numis Securities raised shares of Diploma to an “add” rating and upped their price target for the stock from GBX 2,275 ($29.72) to GBX 3,250 ($42.46) in a research report on Monday, May 17th. Barclays upped their price target on shares of Diploma from GBX 2,710 ($35.41) to GBX 3,040 ($39.72) and gave the stock an “overweight” rating in a research report on Tuesday, May 18th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of GBX 2,787.50 ($36.42).
The company has a debt-to-equity ratio of 52.33, a current ratio of 1.76 and a quick ratio of 0.95. The firm has a market capitalization of £3.69 billion and a PE ratio of 70.81. The business has a 50-day simple moving average of GBX 2,918.15.
Diploma Company Profile (LON:DPLM)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, rest of Europe, North America, and internationally. It operates through three segments: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumable and instrument for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery equipment and consumable for use in hospital operating room; and surgical medical device, and related consumable and service to GI endoscopy suite in hospital and private clinic.
See Also: What is channel trading?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.